12:00 PM, Friday, November 9 through 1:30 PM, Sunday, November 11
The Westin Diplomat Resort & Spa
The Breast Imaging Integration Working Group facilitates collaboration between the Breast Subcommittee of the Early Detection and Diagnosis Committee (Cancer Control and Outcomes Program) and the Breast Committee (Therapeutic Studies Program) for the development of science that involves imaging as a primary or secondary aim.
The meeting summary and accompanying trial overview presentations are posted here to provide an example of the Breast Imaging Integration Working Group as a model for the integration of imaging methods into clinical trials for the detection, diagnosis, and/or treatment of cancer. These presentations are available for interested investigators. Per organizational policy, information about study concepts awaiting approval is not posted publicly. For more information about study concepts in development, please send an email to Dr. Mankoff.
6691 Overview: Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging
6698 Overview: Diffusion-weighted MR Imaging Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: A Substudy of the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis)
6702 Overview: Multicenter Study Evaluating the Utility of Diffusion-weighted Imaging for the Detection and Diagnosis of Breast Cancer
6688 Overview: Phase II Study of 3′-deoxy-3′-[18F] fluorothymidine in Invasive Breast Cancer
University of Virginia Mammography Project: A 3-year, 4000-case project involving a breast density risk model
|Resources for Active Trials|
|NCI-MATCH / EAY131 for Researchers|
|ECOG Performance Status|